Skip to main content
Log in

Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP)

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

The aim of this study is to investigate the frequency and the clinical correlations of pseudobulbar affect (PBA) in a population-based incident cohort of ALS patients. Incident ALS cases, diagnosed in 2011 and 2012, according to El Escorial criteria were enrolled from a prospective population-based registry in Apulia, Southern Italy. Neurological status was assessed using a standard neurological examination and the revised ALS Functional Rating Scale (ALSFRSr). The Center for Neurologic Study-Lability Scale (CNS-LS), a self-administered questionnaire, was used to evaluate the presence and severity of PBA. Total scores range from 7 to 35. A score ≥13 was used to identify the presence of PBA. One-hundred thirty-two sporadic incident ALS cases were enrolled. Median disease duration was 20 months (range 2–143), median onset-diagnosis interval (ODI) 12 months (range 2–131), median ALSFRSr at baseline 36/48 (range 2–47) and median ALSFRSr bulbar sub-score 10/12 (range 0–12). Neurological examination revealed presence of PBA in 34/132 patients (26 %). Pathological CNS-LS score was found in 45/132 patients (34 %). Median total CNS-LS score was 9/35 (range 7–29). The subgroup with pathological CNS-LS was characterized by a short disease duration from symptom onset, ODI, time to diffusion to a second region, time to generalization and ALSFRSr bulbar sub-score, bulbar onset, “definite” diagnostic category, bulbar upper motor-neuron involvement and presence of PBA at neurological examination. In population-based setting, one-third of ALS patients present PBA at diagnosis. The presence of PBA is associated with bulbar UMN involvement and markers of a more severe phenotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dark FL, McGrath JJ, Ron MA (1996) Pathological laughing and crying. Aust N Z J Psychiatry 30:472–479

    Article  CAS  PubMed  Google Scholar 

  2. Starkstein SE, Migliorelli R, Tesón A et al (1995) Prevalence and clinical correlates of pathological affective display in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 59:55–60

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Miller RG, Rosenberg JA, Gelinas DF et al (1999) Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 52:1311–1323

    Article  CAS  PubMed  Google Scholar 

  4. Miller RG, Jackson CE, Kasarskis EJ et al (2009) Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73:1227–1233

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Gallagher JP (1989) Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand 80:114–117

    Article  CAS  PubMed  Google Scholar 

  6. Work SS, Colamonico JA, Bradley WG, Kaye RE (2011) Pseudobulbar affect: an under-recognized and under-treated neurological disorder. Adv Ther 28(7):586–601

    Article  PubMed  Google Scholar 

  7. Floeter MK, Katipally R, Kim MP et al (2014) Impaired corticopontocerebellar tracts underlie pseudobulbar affect in motor neuron disorders. Neurology 83(7):620–627

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lichtner V, Dowding D, Esterhuizen P et al (2014) Pain assessment for people with dementia: a systematic review of systematic reviews of pain assessment tools. BMC Geriatr 14(1):138

    Article  PubMed  PubMed Central  Google Scholar 

  9. Moore SR, Gresham LS, Bromberg MB, Kasarkis EJ, Smith RA (1997) A self report measure of affective lability. J Neurol Neurosurg Psychiatry 63:89–93

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR (1993) Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry 150(2):286–293

    Article  CAS  PubMed  Google Scholar 

  11. Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 124(Suppl):96–107

    Article  PubMed  Google Scholar 

  12. Logroscino G, Beghi E, Zoccolella S et al (2005) SLAP registry. Incidence of amyotrophic lateral sclerosis in Southern Italy: a population-based study. J Neurol Neurosurg Psychiatry 76:1094–1098

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21

    Article  CAS  PubMed  Google Scholar 

  14. Newsom-Davis IC, Abrahams S, Goldstein LH, Leigh PN (1999) The emotional lability questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis. J Neurol Sci 169(1–2):22–25

    Article  CAS  PubMed  Google Scholar 

  15. Ravits J, Laurie P, Fan Y, Moore DH (2007) Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology 68:1576–1582

    Article  PubMed  Google Scholar 

  16. Polymenidou M, Cleveland DW (2011) The seeds of neurodegeneration: prion-like spreading in ALS. Cell 147(3):498–508

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Logroscino G, Traynor BJ, Hardiman O, EURALS et al (2008) Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 79(1):6–11

    Article  CAS  PubMed  Google Scholar 

  18. Palmieri A, Abrahams S, Sorarù G et al (2009) Emotional lability in MND: relationship to cognition and psychopathology and impact on caregivers. J Neurol Sci 278(1–2):16–20

    Article  CAS  PubMed  Google Scholar 

  19. Montuschi A, Iazzolino B, Calvo A et al (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86(2):168–173

    Article  PubMed  Google Scholar 

  20. Phukan J, Elamin M, Bede P et al (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83(1):102–108

    Article  PubMed  Google Scholar 

  21. Consonni M, Iannaccone S, Cerami C et al (2013) The cognitive and behavioural profile of amyotrophic lateral sclerosis: application of the consensus criteria. Behav Neurol 27(2):143–153

    Article  PubMed  PubMed Central  Google Scholar 

  22. McCullagh S, Moore M, Gawel M, Feinstein A (1999) Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction. J Neurol Sci 169(1–2):43–48

    Article  CAS  PubMed  Google Scholar 

  23. Parvizi J, Coburn KL, Shillcutt SD, Coffey CE, Lauterbach EC, Mendez MF (2009) Neuroanatomy of pathological laughing and crying: a report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci 21(1):75–87

    Article  PubMed  Google Scholar 

  24. Pioro EP, Brooks BR, Cummings J, Safety, Tolerability, and Efficacy Results Trial of AVP-923 in PBA Investigators et al (2010) Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol. 68(5):693–702

    Article  CAS  PubMed  Google Scholar 

  25. Seliger GM, Hornstein A (1989) Serotonin, fluoxetine, and pseudobulbar affect. Neurology 39(10):1400

    Article  CAS  PubMed  Google Scholar 

  26. Schoedel KA, Pope LE, Sellers EM (2012) Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers. Clin Drug Investig 32(3):157–169

    Article  CAS  PubMed  Google Scholar 

  27. Wortzel HS, Oster TJ, Anderson CA, Arciniegas DB (2008) Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs 22(7):531–545

    Article  CAS  PubMed  Google Scholar 

  28. Colamonico J, Formella A, Bradley W (2012) Pseudobulbar affect: burden of illness in the USA. Adv Ther 29(9):775–798

    Article  PubMed  Google Scholar 

  29. Brooks BR, Crumpacker D, Fellus J, Kantor D, Kaye RE (2013) PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions. PLoS ONE 8(8):e72232

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giancarlo Logroscino.

Ethics declarations

Funding

European Community’s Seventh Framework Programme (FP7/2007-2013 under Grant agreement 259867).

Conflicts of interest

All authors declare no conflict of interest.

Ethical standards

The study was approved by the Institutional Review Board of Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tortelli, R., Copetti, M., Arcuti, S. et al. Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP). J Neurol 263, 316–321 (2016). https://doi.org/10.1007/s00415-015-7981-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-015-7981-3

Keywords

Navigation